Literature DB >> 18342901

Revisiting cangitoxin, a sea anemone peptide: purification and characterization of cangitoxins II and III from the venom of Bunodosoma cangicum.

André Junqueira Zaharenko1, Wilson Alves Ferreira, Joacir Stolarz de Oliveira, Katsuhiro Konno, Michael Richardson, Emanuele Schiavon, Enzo Wanke, José Carlos de Freitas.   

Abstract

Sodium channel toxins from sea anemones are employed as tools for dissecting the biophysical properties of inactivation in voltage-gated sodium channels. Cangitoxin (CGTX) is a peptide containing 48 amino acid residues and was formerly purified from Bunodosoma cangicum. Nevertheless, previous works reporting the isolation procedures for such peptide from B. cangicum secretions are controversial and may lead to incorrect information. In this paper, we report a simple and rapid procedure, consisting of two chromatographic steps, in order to obtain a CGTX analog directly from sea anemone venom. We also report a substitution of N16D in this peptide sample and the co-elution of an inseparable minor isoform presenting the R14H substitution. Peptides are named as CGTX-II and CGTX-III, and their effects over Nav1.1 channels in patch clamp experiments are demonstrated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342901     DOI: 10.1016/j.toxicon.2008.01.011

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

Review 1.  Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: an overview.

Authors:  Bárbara Frazão; Vitor Vasconcelos; Agostinho Antunes
Journal:  Mar Drugs       Date:  2012-08-22       Impact factor: 6.085

2.  Phyla- and Subtype-Selectivity of CgNa, a Na Channel Toxin from the Venom of the Giant Caribbean Sea Anemone Condylactis Gigantea.

Authors:  Bert Billen; Sarah Debaveye; Lászlo Béress; Anoland Garateix; Jan Tytgat
Journal:  Front Pharmacol       Date:  2010-11-23       Impact factor: 5.810

Review 3.  A Review of Toxins from Cnidaria.

Authors:  Isabella D'Ambra; Chiara Lauritano
Journal:  Mar Drugs       Date:  2020-10-06       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.